Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-03-04

Last Posted Date: 2013-01-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00005035

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States

and more 8 locations

Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

First Posted Date: 2004-02-25

Last Posted Date: 2013-01-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00005864

Locations: 🇺🇸
Central Baptist Hospital, Lexington, Kentucky, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

and more 1 locations

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

Phase 2

Completed

Conditions: Gastrointestinal Carcinoid Tumor
Islet Cell Tumor

First Posted Date: 2004-02-16

Last Posted Date: 2013-01-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00017199

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2003-06-06

Last Posted Date: 2014-02-11

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 25

Registration Number: NCT00061906

Locations: 🇺🇸
Ohio State University Comrehensive Cancer Center, Columbus, Ohio, United States
🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

Combination Chemotherapy in Treating Patients With Solid Tumors

Phase 1

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-06-06

Last Posted Date: 2013-05-15

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00009932

Locations: 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

FR901228 in Treating Patients With Hematologic Cancer

Phase 1

Completed

Conditions: Leukemia
Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-01-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00024180

Locations: 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Phase 1

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2013-05-15

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00004173

Locations: 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy